Triple negative breast cancer can be extremely aggressive and more likely to reoccur and metastasize than other subtypes of breast cancer. It typically is responsive to chemotherapy, although it can be more difficult to treat because it is unresponsive to the most effective receptor targeted treatments. This free case-based course highlights current treatment strategies for this disease.
- Improve understanding of basil-like and triple negative breast cancer (TNBC) to reduce risk of relapse and apply knowledge learned to patient care
- Identify patients at diagnosis who will not be cured by chemotherapy and assess the potential use of alternate treatment options as appropriate
- Discuss potential new strategies for treatment of TNBC and assess their practical benefits and limitations to inform decision making
- Enhance understanding of estrogen receptors, progesterone receptors and human epidermal growth factor receptor 2 (HER2) specific to patients with TNBC
ACGME Competencies addressed: Medical Knowledge; Practice-based Learning & Improvement
Note: This course is now accessible through iPads as well as personal computers